Evidence map›Paper›PMID 38272118›Full record

Trial reportJournal of substance use and addiction treatment2024

Disclosing Recovery: A pilot randomized controlled trial of a patient decision aid to improve disclosure processes for people in treatment for opioid use disorder.

Valerie A Earnshaw, Karen R Sepucha, Jean-Philippe Laurenceau, S V Subramanian, E Carly Hill, James Wallace, Natalie M Brousseau, Claire Henderson, Elaine Brohan, Lynn M Morrison and 1 more

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of substance use and addiction treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Valerie A EarnshawDepartment of Human Development and Family Sciences, University of Delaware, 111 Alison Hall West, Newark, DE 19716, USA. Electronic address: earnshaw@udel.edu.
Karen R SepuchaHealth Decision Sciences Center, Massachusetts General Hospital, 100 Cambridge St, Suite 1600, Boston, MA 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA. Electronic address: KSEPUCHA@mgh.harvard.edu.
Jean-Philippe LaurenceauDepartment of Psychological and Brain Sciences, University of Delaware, 231 Wolf Hall, Newark, DE 19716, USA. Electronic address: jlaurenc@udel.edu.
S V SubramanianHarvard Center for Population and Development Studies, Cambridge, MA, USA; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Electronic address: svsubram@hsph.harvard.edu.
E Carly HillDepartment of Human Development and Family Sciences, University of Delaware, 111 Alison Hall West, Newark, DE 19716, USA; Center for Research on Education and Social Policy, University of Delaware, 125 Academy Street, Newark, DE 19716, USA. Electronic address: ehill@udel.edu.
James WallaceCenter for Research on Education and Social Policy, University of Delaware, 125 Academy Street, Newark, DE 19716, USA; Department of Epidemiology, University of Delaware, 100 Discovery Blvd, Newark, DE 19716, USA. Electronic address: jawall@udel.edu.
Natalie M BrousseauGraduate School of Applied and Professional Psychology, Rutgers University, 152 Frelinghuysen Rd, Piscataway, NJ 08854-8020, USA. Electronic address: nbrousseauu@gmail.com.
Claire HendersonHealth Services and Population Research Department, King's College London Institute of Psychiatry, Psychology and Neuroscience, United Kingdom of Great Britain and Northern Ireland. Electronic address: Claire.1.Henderson@kcl.ac.uk.
Elaine BrohanHealth Services and Population Research Department, King's College London Institute of Psychiatry, Psychology and Neuroscience, United Kingdom of Great Britain and Northern Ireland. Electronic address: elaine.brohan@kcl.ac.uk.
Lynn M MorrisonBrandywine Counseling and Community Services, 2713 Lancaster Avenue, Wilmington, DE 19805, USA. Electronic address: lmorrison@brandywinecounseling.org.
John F KellyHarvard Medical School, 25 Shattuck St, Boston, MA 02115, USA; Recovery Research Institute, Massachusetts General Hospital, 151 Merrimac St, 6th Floor, Boston, MA 02114, USA. Electronic address: JKELLY11@mgh.harvard.edu.
University of Delaware · USKing's College London · GBMassachusetts General Hospital · USBrandywine Photonics (United States) · USHarvard University · USUniversity of Connecticut · US

Funding

Mentoring in Patient-Oriented Addiction ResearchK24AA022136 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI KELLY, JOHN F. · 2014 to 2023
$1.8M
Understanding and Addressing Disclosure to Members of Social Networks among People Recovering from Substance Use DisordersK01DA042881 · NIDA · UNIVERSITY OF DELAWARE · PI EARNSHAW, VALERIE ANN · 2017 to 2020
$756k
NIAAA NIH HHS K24 AA022136NIDA NIH HHS K01 DA042881
6 · The paper itself

Abstract

introductionPeople engaged in treatment for opioid use disorder (OUD) report struggling with whether and how to disclose, or share information about their OUD history and/or treatment with others. Yet, disclosure can act as a gateway to re-establishing social connection and support during recovery. The current study describes a pilot randomized controlled trial of Disclosing Recovery: A Decision Aid and Toolkit, a patient decision aid designed to facilitate disclosure decisions and build disclosure skills.

methodsParticipants (n = 50) were recruited from a community-based behavioral health organization in 2021-2022 and randomized to receive the Disclosing Recovery intervention versus an attention-control comparator. They responded to surveys immediately after receiving the intervention as well as one month following the intervention at a follow-up appointment. Primary outcome analyses examined indicators of implementation of the intervention to inform a future efficacy trial. Secondary outcome analyses explored impacts of the intervention on the decision-making process, disclosure rates, and relationships.

resultsParticipants were successfully recruited, randomized, and retained, increasing confidence in the feasibility of future efficacy trials to test the Disclosing Recovery intervention. Moreover, participants in the Disclosing Recovery intervention agreed that the intervention is acceptable, feasible, and appropriate. They additionally reported a higher quality of their decision-making process and decisions than participants in the comparator condition. At their follow-up appointment, participants with illicit opioid use who received the Disclosing Recovery intervention were less likely to disclose than those who received the comparator condition. Moreover, significant interactions between illicit opioid use and the intervention condition indicated that participants without illicit opioid use who received the Disclosing Recovery intervention reported greater closeness to and social support from their planned disclosure recipient than those who received the comparator condition.

conclusionsThe Disclosing Recovery intervention appears to be an acceptable, feasible, and appropriate patient decision aid for addressing disclosure processes among people in treatment for OUD. Moreover, preliminary results suggest that it shows promise in improving relationship closeness and social support in patients without illicit opioid use. More testing is merited to determine the intervention's efficacy and effectiveness in improving relationship and treatment outcomes for people in treatment for OUD.

Indexed as

Decision Support TechniquesOpioid-Related DisordersAdultDecision MakingDisclosureFemaleHumansMaleMiddle AgedPilot ProjectsDisclosureOpioid use disorderPatient decision aidRandomized controlled trial

Identifiers

PMID38272118
PMCPMC11060902
OpenAlexW4391147725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.